Statin therapy in patients with high and very high cardiovascular risk: an optimal approach

QR Code

Statin therapy in patients with high and very high cardiovascular risk: an optimal approach

This article discusses the problems of adequate therapy for dys-lipidemia in patients with high and very high cardiovascular risk in clinical practice. Updated Russian and European guidelines for the treatment of dyslipidemia pick out five categories of cardiovascular risk and clarify goals of preve...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. V. Sayutina, M. M. Shamuilova, L. I. Butorova, E. M. Tuayeva, A. L. Vertkin
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2020-11-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	dyslipidemia very high cardiovascular risk intensive statin therapy atherosclerosis rosuvastatin
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2696
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE
by: L. N. Malay
Published: (2015-09-01)

Comparative effectiveness of statin therapy in patients with hypertension of high and very high cardiovascular risk in actual clinical practice in Irkutsk
by: O. A. Ivanova, et al.
Published: (2021-11-01)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015-12-01)

EFFECTIVENESS OF ROSUVASTATIN IN VERY HIGH RISK CARDIOVASCULAR PATIENTS IN THE ACTUAL OUTPATIENT PRACTICE
by: V. P. Mikhin, et al.
Published: (2015-12-01)

ROSUVASTATIN - THE MOST POTENT STATIN IN CARDIOVASCULAR DISEASE PREVENTION
by: A. E. Semenova, et al.
Published: (2018-06-01)

Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study)
by: S. Yu. Martsevich, et al.
Published: (2019-01-01)

HYPOLIPIDEMIC AND PLEIOTROPIC EFFICACY OF ROSUVASTATIN IN ARTERIAL HYPERTENSION PATIENTS OF HIGH CARDIOVASCULAR RISK IN LONG-TERM OUTPATIENT FOLLOW-UP
by: V. P. Mikhin, et al.
Published: (2016-12-01)

Intensification of lipid-lowering therapy in very high-risk patients: potential of combination with PCSK9 inhibitors
by: D. Yu. Sedykh, et al.
Published: (2022-07-01)

Features and main problems of treating patients with high and very high cardiovascular risk with statins in real clinical practice (according to the data of the “PRIORITET” research)
by: S. Yu. Martsevich, et al.
Published: (2018-12-01)

Efficacy and safety of inclisiran, evolocumab and alirocumab in patients with high, very high and extreme cardiovascular risk
by: N. G. Lozhkina, et al.
Published: (2025-04-01)

Efficacy and safety of statin therapy in multimorbid outpatients with very high cardiovascular risk
by: N. V. Izmozherova, et al.
Published: (2020-07-01)

STATINS AND MYOPATHY: MOLECULAR MECHANISMS
by: O. M. Drapkina, et al.
Published: (2015-12-01)

A randomized controlled trial of statin therapy effect on androgen status and erectile function in men with high and very high cardiovascular risk (TRISTAN): rationale and study protocol
by: K. P. Raevskii, et al.
Published: (2025-06-01)

Statin Therapy and Cognitive Impairment: Benefit or Harm?
by: O. D. Ostroumova, et al.
Published: (2018-09-01)

THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT?
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS
by: A. N. Meshkov
Published: (2015-12-01)

Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice
by: D. V. Nebieridze, et al.
Published: (2020-09-01)

Adherence to statin therapy in patients with high and very high cardiovascular risk in real clinical practice
by: V. I. Podzolkov, et al.
Published: (2020-03-01)

Place of renin-angiotensin-aldosterone system inhibitors and statins in the treatment of cardiovascular patients in the context of COVID-19 pandemic
by: E. V. Sayutina, et al.
Published: (2022-03-01)

Register of patients with familial hypercholesterolemia and patients of very high cardiovascular risk with lipid-lowering therapy underperformance (RENESSANS)
by: M. V. Yezhov, et al.
Published: (2019-06-01)

THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA?
by: S. N. Bel'diev
Published: (2016-06-01)

Pitavastatin – a new inhibitor of the HMG-CoA reductase: peculiarities of clinical pharmacology and perspectives of its usage in treatment of cardiovascular diseases.
by: G. V. Dzyak, et al.
Published: (2013-12-01)

Modern possibilities of antihypertensive and lipid-lowering therapy in the treatment of comorbid patients with a very high risk of cardiovascular events
by: V. I. Podzolkov, et al.
Published: (2023-07-01)

Muscular and Renal Safety of Ticagrelor with High-Intensity Statins: Retrospective Cohort Findings
by: Alshammari AS, et al.
Published: (2025-06-01)

Modern algorithms for statin therapy
by: V. A. Susekov
Published: (2023-11-01)

THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY
by: V. V. Kukharchuk, et al.
Published: (2013-06-01)

SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION
by: S. N. Bel'diev
Published: (2017-03-01)

METABOLIC EFFECTS OF STATINS AND CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS
by: E. I. Yakovenko, et al.
Published: (2012-04-01)

Combined hypolipidemic therapy in patients who failed to achieve target values of the lipidogram. Possibilities of ezetimibe
by: N. V. Fedorova, et al.
Published: (2021-06-01)

Prognostic significance of atherosclerosis of one or two vascular systems in patients with high and very high cardiovascular risk
by: V. V. Genkel, et al.
Published: (2021-03-01)

We act as early as possible and prescribe for as long as possible! Individualised approach to statin therapy
by: M. V. Chirkova
Published: (2024-11-01)

Effectiveness of patient-oriented intervention in primary prevention of cardiovascular diseases with statins: Open-label randomized study
by: Elena Bochkareva, et al.
Published: (2025-06-01)

Prevalence and predictors of statin therapy in the general working-age population
by: V. S. Kaveshnikov, et al.
Published: (2020-07-01)

Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits
by: S. A. Davitashvili, et al.
Published: (2021-03-01)

STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY)
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

An integrated approach for very high cardiovascular risk patients. Intermediate results
by: E. I. Usova, et al.
Published: (2022-02-01)

HYPOLIPIDEMIC THERAPY IN PATIENTS AFTER HEART TRANSPLANTATION: STATINS
by: A. О. Shevchenko
Published: (2016-06-01)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS
by: M. A. Vorobyeva, et al.
Published: (2017-09-01)

REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER)
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)